The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study
Open accessAbstract
AIM: The Framingham risk score (FRS) is one of the standard tools used to predict the incidence of coronary heart disease (CHD). No previous study has investigated its efficacy for a Japanese population cohort. The purpose of this study was to develop new coronary prediction algorithms for the Japanese population in the manner of the FRS, and to compare them with the original FRS. METHODS: Our coronary prediction algorithms for Japanese were based on a large population-based cohort study (Suita study). The study population comprised 5,521 healthy Japanese. They were followed-up for 11.8 years on average, and 213 cases of CHD were observed. Multiple Cox proportional hazard model by stepwise selection was used to construct the prediction model. RESULTS: Our coronary prediction algorithms for Japanese patients were based on a large populationbased cohort study (the Suita study). A multiple Cox proportional hazard model by stepwise selection was used to construct the prediction model. The C-statistics showed that the new model had better accuracy than the original and recalibrated Framingham scores. The net reclassification improvement (NRI) by the Suita score with the inclusion of CKD was 41.2% (P<0.001) compared with the original FRS. The recalibration of the FRS slightly improved the efficiency of the prediction, but it was still worse than the Suita score with the CKD model. The calibration analysis suggested that the original FRS and the recalibrated FRS overestimated the risk of CHD in the Japanese population. The Suita score with CKD more accurately predicted the risk of CHD. CONCLUSION: The FRS and recalibrated FRS overestimated the 10-year risk of CHD for the Japanese population. A predictive score including CKD as a coronary risk factor for the Japanese population was more accurate for predicting CHD than the original Framingham risk scores in terms of the C-statics and NRI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In terms of absolute risk, aging enhances the risk for ASCVD and death from it much more than any other risk factors160–162).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [161]
In the citing paper
“There are several assessment tool that predict the absolute risk of ASCVD in the Japanese population.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Steyerberg, E. W. (2010) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,483
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,337
Flagged first, then by citations
2 of the 58 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 225
Adachi, H., Enomoto, M., Fukami, A., Nakamura, S., Nohara, Y., Kono, S., Sakaue, A., Hamamura, H., Toyomasu, K., Yamamoto, M., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01561-9 · Cited by 8
Wada, S., Iwanaga, Y., Nakai, M., Nakao, Y. M., Miyamoto, Y., & Noguchi, T. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.04.006 · Cited by 9
Self-citationArafa, A., Kashima, R., Yasui, Y., Kawachi, H., Matsumoto, C., Nosaka, S., Teramoto, M., Matsuo, M., & Kokubo, Y. (2023) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.23-00099 · Cited by 7
“In this context, we previously developed risk models predicting stroke [4], CHD [5], and CVD [6] using data from the Suita Study, a prospective cohort study representing the general population in urban Japan.”
MethodSelf-citationTriglycerides and the Risk of Atherosclerotic Cardiovascular Events Across Different Risk Categories
Mizuta, H., Ishii, M., Ikebe, S., Otsuka, Y., Yamanouchi, Y., Nakamura, T., & Tsujita, K. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65334 · Cited by 8
Fujishima, S., Kodama, S., & Tsuchihashi, T. (2020) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2020.1764017 · Cited by 7
Watanabe, K., Hada, Y., Ishii, K., Nagaoka, K., Takase, K., Kameda, W., Susa, S., Saigusa, T., Egashira, F., Ishihara, H., et al. (2021) · Heart and Vessels · doi:10.1007/s00380-021-01948-2 · Cited by 7
Chang, H., Fang, H., Huang, C.-Y., Chiang, C.-Y., Chuang, S., Hsu, C., Cheng, H., Chen, T., Yao, W.-C., & Pan, W. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031319 · Cited by 7
Takeshita, M., Tabara, Y., Setoh, K., Nagao, K., Imaizumi, A., Kageyama, Y., Matsuda, F., Tabara, Y., Kawaguchi, T., Setoh, K., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.10.024 · Cited by 7
Sugiura, T., Dohi, Y., Takagi, Y., Yokochi, T., Yoshikane, N., Suzuki, K., Tomiishi, T., Nagami, T., Iwase, M., Takase, H., et al. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.59857 · Cited by 7
Zhu, Q., Luo, D., Zhou, X., Cai, X., Li, Q., Lu, Y., & Chen, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126584 · Cited by 7
Onozaki, A., Nagayama, D., Azuma, N., Sugai, K., 設樂悦子, Sakai, T., Masai, M., Shirai, K., & Tatsuno, I. (2021) · Obesity Facts · doi:10.1159/000518049 · Cited by 7
Shinohara, H., Kodera, S., Nagae, Y., Hiruma, T., Kobayashi, A., Satô, M., Sawano, S., Kamon, T., Narita, K., Hirose, K., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304423 · Cited by 6
“Accurate patient risk stratification is crucial for optimizing treatment, and the effectiveness of scoring systems, such as the Suita score, has been well-documented [3].”
BackgroundMori, Y., Komura, T., Adomi, M., Yagi, R., Fukuma, S., Kawakami, K., Kondo, N., Tsugawa, Y., Yabe, D., Yanagita, M., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf539 · Cited by 6
Sex differences in the progression of cardiovascular–kidney–metabolic syndrome
Taya, S., Ejiri, K., Kaneko, H., Suzuki, Y., Miyoshi, T., Mizuno, A., Ko, T., Jimba, T., Azegami, T., Okada, A., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf162 · Cited by 6
Inadome, N., Kawasoe, S., Miyata, M., Kubozono, T., Ojima, S., Mori, R., Miyahara, H., Tokushige, K., & Ohishi, M. (2025) · Hypertension Research · doi:10.1038/s41440-024-02057-z · Cited by 6
“In contrast, the Suita score, developed for Japanese subjects, includes age, sex, SBP, DBP, LDL-C, HDL-C, DM, smoking, and CKD as risk factors [26].”
Sata, M., Okamura, T., Harada, S., Sugiyama, D., Kuwabara, K., Hirata, A., Takeuchi, A., Iida, M., Kato, S., Matsumoto, M., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.58719 · Cited by 6
Self-citationGlucose variability and predicted cardiovascular risk after gastrectomy
Shibamoto, J., Kubota, T., Ohashi, T., Konishi, H., Shiozaki, A., Fujiwara, H., Okamoto, K. K., & Otsuji, E. (2022) · Surgery Today · doi:10.1007/s00595-022-02496-6 · Cited by 8
“The Suita score was published as the original formula for predicting the probability of CHD events within 10 years [12].”
BackgroundMethodSekiya, R., Muramatsu, T., Ichiki, A., Chikasawa, Y., Bingo, M., Yotsumoto, M., Hagiwara, T., Amano, K., & Kinai, E. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.10.014 · Cited by 6
New 2019 JSH guidelines and the risk of incident cardiovascular disease: The Suita Study
Arafa, A., Kashima, R., & Kokubo, Y. (2022) · Hypertension Research · doi:10.1038/s41440-022-01142-5 · Cited by 6
“In line with these findings, previous studies using data from the Suita Study showed that participants with an SBP of 120–139 mmHg had a higher risk of stroke [10], CHD [11], atrial fibrillation [12], and CVD [13] than those with an SBP < 120 mmHg.”
ResultSelf-citationOsaki, T., Satoh, M., Tanaka, F., Tanno, K., Takahashi, Y., Nasu, T., Sakata, K., Morino, Y., Sobue, K., & Sasaki, M. (2019) · Journal of Epidemiology · doi:10.2188/jea.je20180274 · Cited by 6
Yasuda, K., Tomoda, S., Suzuki, M., Wada, T., Fujikawa, T., Kikutsuji, T., & Kato, S. (2024) · AJPM Focus · doi:10.1016/j.focus.2024.100277 · Cited by 8
Suzuki, K., Tsujiguchi, H., Hara, A., Takeshita, Y., Goto, H., Nakano, Y., Yamamoto, R., Takayama, H., Tajima, A., Yamashita, T., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14351 · Cited by 5
Yamasaki, M., Yano, S., Takeda, M., Abe, T., Isomura, M., Hamano, T., Nabika, T., & Shiwaku, K. (2020) · Journal of Rural Medicine · doi:10.2185/jrm.2019-008 · Cited by 5
Primary Prevention of Coronary and Other Cardiovascular Diseases: A Focused Review
Higashiyama, A., Kohsaka, S., & Fujiyoshi, A. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22019 · Cited by 6
“However, risk prediction models constructed based on populations in Europe or the USA tend to overestimate the risk of CAD in cohort studies in Japan 10) .”
BackgroundSelf-citationTai, P. H. A. M., Fujiyoshi, A., Arima, H., Tanaka‐Mizuno, S., Hisamatsu, T., Kadowaki, S., Kadota, A., Zaid, M., Sekikawa, A. M., Yamamoto, T., et al. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.42416 · Cited by 5
Naya, M., Uemura, Y., Matsumoto, N., Momose, M., Kato, T., Hida, S., Yamauchi, T., Nakajima, T., Suzuki, E., & Tamaki, N. (2018) · Coronary Artery Disease · doi:10.1097/mca.0000000000000645 · Cited by 5
Comprehensive Risk Management Chart for the Prevention of Cerebro- and Cardiovascular Diseases
脳心血管病予防に関する包括的リスク管理合同会議 (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.824 · Cited by 5
Tabara, Y., Shoji‐Asahina, A., Akasaka, H., Sugimoto, K., & Sato, Y. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.15078 · Cited by 4
Sheikh, A., Nurmatov, U. B., Al-Katheeri, H. A., & Huneiti, R. A. (2021) · Qatar medical journal · doi:10.5339/qmj.2021.42 · Cited by 5
“54 PREDICT risk score was better than PCE in one study (Supplementary file: Table 3b).(50) Calibration Calibration performance was reported in 21 (51%) studies (Supplementary file: Table 4).”
BackgroundMethodResultInfluentialJiu, L., Wang, J., Somolinos-Simón, F. J., Tapia, J. A. R., García-Sáez, G., Hernando, M. E., Li, X., Vreman, R. A., Mantel-Teeuwisse, A. K., & Goettsch, W. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111574 · Cited by 4
Ohno, Y., Shibazaki, S., Araki, R., Miyazaki, T., Sato, M., Takahashi, S., Suwa, E., Takenaka, T., & Suzuki, H. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6247 · Cited by 4
A New Risk Score for Patients With Acute Chest Pain and Normal High Sensitivity Troponin
Ma, C., Liu, X., & Ma, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.728339 · Cited by 4
Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease
Akuta, N., Kawamura, Y., Fujiyama, S., Nakamichi, K., Saegusa, E., Ogura, H., Kato, M., Doi, E., Inoue, N., Sezaki, H., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13968 · Cited by 4
Chien, K., Lin, H., Su, T., Chen, Y., & Chen, P. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-0910 · Cited by 4
Nasu, T., Satoh, M., Hachiya, T., Sutoh, Y., Ohmomo, H., Hitomi, S., Taguchi, S., Kikuchi, H., Kobayashi, T., Takahashi, Y., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.12.019 · Cited by 4
Shinohara, K., Ikeda, S., Enzan, N., Matsushima, S., Tohyama, T., Funakoshi, K., Kishimoto, J., Itoh, H., Komuro, I., & Tsutsui, H. (2021) · Hypertension Research · doi:10.1038/s41440-021-00734-x · Cited by 4
Comprehensive Risk Management Chart for Cerebro-cardiovascular Disease 2019
脳心血管病協議会 (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.1024 · Cited by 4
Sekizuka, H., & Miyake, H. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100200 · Cited by 4
MATSUMOTO-YAMAUCHI, H., Kondo, K., Miura, K., Tanaka‐Mizuno, S., Segawa, H., Ohno, S., Miyagawa, N., Zaid, M., Okami, Y., Okuda, N., et al. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.28 · Cited by 3
Self-citationSaigusa, T., Watanabe, K., Hada, Y., Ishii, K., Kameda, W., Susa, S., Ishizawa, K., & Ishihara, H. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02800-9 · Cited by 4
“The Suita score is an established cardiovascular risk score based on risk factor categories for predicting CHD in the Japanese population [15].”
BackgroundInfluentialNagai, R., Kubota, S., Ogata, M., Yamamoto, M., Tanuma, J., Gatanaga, H., Hara, H., Oka, S., & Hiroi, Y. (2020) · Global Health & Medicine · doi:10.35772/ghm.2020.01080 · Cited by 3
Ikeda, S., Shinohara, K., Enzan, N., Matsushima, S., Tohyama, T., Funakoshi, K., Kishimoto, J., Itoh, H., Komuro, I., & Tsutsui, H. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002823 · Cited by 3
Zhou, X., Zhou, S., Li, Y., Qian, Z., Zeng, C., & Li, Y. (2022) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2021-0183 · Cited by 3
“Also, the number of deaths caused by CHD is rising[5].”
BackgroundChristopher, O., Xiong, Z., Huang, Y., Zhuang, X., Zhang, S., Liu, M., Guo, Y., & Liao, X. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.12.023 · Cited by 4
A Simple Modified Framingham Scoring System to Predict Obstructive Coronary Artery Disease
Liu, Y., Li, Q., Chen, S., Wang, X., Zhou, Y., Tan, N., & Chen, J. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9837-6 · Cited by 3
Miyamoto, Y., Itaya, T., Terasawa, Y., & Kohriyama, T. (2022) · Internal Medicine · doi:10.2169/internalmedicine.7905-21 · Cited by 3
“However, because the present study was conducted in Japan, we utilized the Suita score, a CHD risk evaluation algorithm developed using data from the general Japanese population that adds chronic kidney disease (CKD) to the FRS (8).”
MethodInfluentialSelf-citationTotal-body dynamic PET/CT imaging reveals kinetic distribution of [13N]NH3 in normal organs
Liu, G., Gu, T., Chen, S., Gu, Y., Yu, H., & Shi, H. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06826-3 · Cited by 3
“Eleven subjects who had a low likelihood of myocardial ischemia were enrolled to this study, according to the Fram - ingham Heart Study Group [ 23].”
MAFLD AND NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality?
Lombardi, R., Cespiati, A., Francione, P., Cinque, F., Fargion, S. R., & Fracanzani, A. L. (2021) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.13 · Cited by 3
Kikuchi, H., Nasu, T., Satoh, M., Kotozaki, Y., Tanno, K., Asahi, K., Ohmomo, H., Kobayashi, T., Taguchi, S., Morino, Y., et al. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.101056 · Cited by 3
Munakata, M. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed215 · Cited by 3
Suh, J., Memtsas, V., Gue, Y. X., Cho, H.-W., Lee, W., Kang, S., & Gorog, D. A. (2023) · Thrombosis and Haemostasis · doi:10.1055/s-0043-1777794 · Cited by 2
Niwa, Y., Naruse, H., Kawai, H. D., Sakaguchi, E., Ishihara, Y., Hattori, H., Uehara, K., Ito, M., Yamada, S., Yamada, A., et al. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65904 · Cited by 2
“Recent studies have shown associations between Lp(a) levels and HRP The Suita score is a risk assessment tool that estimates the 10-year probability of developing cardiovascular disease and is considered more practical for Japanese patients, with better predictive performance than the Framingham Risk Score 19) .”
InfluentialWada, S., Sakuraba, M., Nakai, M., Suzuki, T., Miyamoto, Y., Noguchi, T., & Iwanaga, Y. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3566-24 · Cited by 2
“The Framingham and Suita risk scores of the patients were calculated using clinical data to assess the clinical risk for MACEs (4, 5).”
Self-citationBan, J.-W., Abel, L., Stevens, R., & Perera, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310321 · Cited by 2
Bekler, Ö., & Kurtul, A. (2025) · Medicina · doi:10.3390/medicina61050794 · Cited by 2
“Finally, large-scale multicenter trials using advanced diagnostic tools are required to validate the prognostic value of non-dipping patterns and clarify underlying mechanisms.”
Watanabe, R. R., Nakatani, E., Kaneda, H., Funaki, D., Sobukawa, Y., Tanaka, Y., Kuriyama, N., Takeuchi, M., & Sugawara, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-11236-y · Cited by 2
“High CVD risk was defined as a 10-year probability of 10% or greater, based on the Hisayama study 28 or 9% or greater (Suita score ≥ 56), based on the Suita study 29 .”
Osada, Y., Arakaki, H., Takanashi, S., Ito, C., Aisa, Y., & Nakazato, T. (2017) · Medical Oncology · doi:10.1007/s12032-017-0922-5 · Cited by 2
Abe, M., Masunaga, N., Ishii, M., Doi, K., Ishigami, K., Ikeda, S., Aono, Y., An, Y., Iguchi, M., Esato, M., et al. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.09.014 · Cited by 2
Nasr, N. M. G., Soltész, B., Sándor, J., Ádány, R., & Fiatal, S. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9090295 · Cited by 3
Chalwe, J. M., Grobler, C. J., & Oldewage-Theron, W. H. (2023) · Nutrients · doi:10.3390/nu15112470 · Cited by 2
“Additionally, they have been reported to overestimate the CVD risks in some cases [4,5].”
BackgroundMethodOnishi, S., Fukuda, A., Matsui, M., Ushiro, K., Nishikawa, T., Asai, A., Kim, S. K., & Nishikawa, H. (2023) · Nutrients · doi:10.3390/nu15224816 · Cited by 2
“Since the Suita score is for those 35 years of age and older, those under 35 were excluded [1].”
BackgroundMethodInfluentialMuraki, I. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed144 · Cited by 2
Protecting young and middle-aged adults from a high risk of mortality owing to various risk factors
Tatsumi, Y. (2024) · Hypertension Research · doi:10.1038/s41440-024-01822-4 · Cited by 2
“These scores include many risk factors and yield higher probabilities with older age [1, 2].”
Cardiac Risk in Prediction Models
Adachi, H. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed149 · Cited by 1
Sadatani, K., Niiya, K., Miyamoto, I., Nakano, M., Habara, T., & Sezaki, N. (2021) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000001037 · Cited by 1
Taya, N., Katakami, N., Omori, K., Hosoe, S., Watanabe, H., Takahara, M., Miyashita, K., Konya, Y., Obara, S., Hidaka, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146977 · Cited by 1
“Finally, we investigated whether adding total DG values to the standard atherosclerosis prediction model, which includes the Suita score (an established Japanese risk score for coronary heart disease) [12], HbA1c levels, and baseline CIMT, could improve the predictive ability for annual CIMT change.”
Immunological Diagnosis and Treatments of Periodontitis in Patients with Type 2 Diabetes Mellitus
Yoshida, K., Iwasaki, K., Uehara, O., Kato, S., Shimizu, S., Sato, K., Sugiyama, N., Okada, Y., Fujimoto, Y., Hirose, S., et al. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03176-1_10 · Cited by 1
Azegami, T., Kaneko, H., Suzuki, Y., Okada, A., Ko, T., Jimba, T., Ejiri, K., Mizuno, A., Fujiu, K., Takeda, N., et al. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012921 · Cited by 1
Chew, N., Kong, G., Cader, F. A., Chen, Y., Chong, B., Chow, C. K., Goh, R. J. L., Grey, C., Guo, Y., Himan, H. R., et al. (2026) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2026.101902 · Cited by 1
Nakamura, H., Sato, K. A., Hirayama, K., Hayashi, Y., & Tokunaga, Y. (2022) · Cureus · doi:10.7759/cureus.23591 · Cited by 1
“In addition, the SS LDL-C version was calculated based on age, HDL-C, LDL-C, systolic blood pressure, diabetes mellitus, current smoking status, and estimated glomerular filtration rate (eGFR) [9].”
BackgroundMethodYamashita, S. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.73 · Cited by 1
Oyama, S., Takahashi, H., Hayashi, H., Koide, S., Nakai, S., Takahashi, K., Inaguma, D., Hasegawa, M., Ishii, J., Yuzawa, Y., et al. (2023) · PubMed Central · doi:10.20407/fmj.2022-004 · Cited by 1
Ma, E., Ohira, T., Miyazaki, M., Fukasawa, M., Yoshimoto, M., Suzuki, T., Furuyama, A., Kataoka, M., Yasumura, S., & Hosoya, M. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64018 · Cited by 1
“The Japanese Suita prediction scores were modified and developed in 2015 from the Framingham scores 10) .”
MethodLim, H., Han, H., Won, S., Ji, S.-I., Park, Y. H., & Lee, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0292067 · Cited by 1
Takura, T., Yokoi, H., & Honda, A. (2024) · JMIR Aging · doi:10.2196/59234 · Cited by 1
Wang, X., You, J., Tang, J., Li, X., Wang, R., Li, Y., Yin, C., Bai, Y., Wang, M., & Zheng, S. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.103799 · Cited by 1
Shrestha, R., Chen, Z., Gao, Z., Chen, Y., Okada, E., Ukawa, S., Nakagawa, T., Nakamura, K., Tamakoshi, A., Chiba, H., et al. (2021) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632211007157 · Cited by 1
Gill, H., Rodrigues, N. B., Mansur, R. B., Marks, C. A., Vincenzo, J. D. D., Ceban, F., Rosenblat, J. D., Cao, B., Lieberman, J. M., Ho, R., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.020 · Cited by 3
A Risk Prediction Model of Atherosclerotic Cardiovascular Disease in Japan
Saito, I. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed172 · Cited by 1
The Estimated Absolute Risk of Coronary Artery Disease and Subclinical Atherosclerosis
Kadota, A. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed177 · Cited by 1
Yoshio, S. (2021) · Hepatology Research · doi:10.1111/hepr.13717 · Cited by 1
Vu, T., Kokubo, Y., Inoue, M., Yamamoto, M., Mohsen, A. S., Morales, A. M., Inoué, T., Ting, T. J., Yoshizaki, M., Watanabe, N., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4120297/v1 · Cited by 3
Self-citationConditions of Non-Unique Identifiers in Record Linkage Using Japanese Cohort Dataset
Nakai, M., Nishimura, K., & Miyamoto, Y. (2015) · Journal of Data Analysis and Information Processing · doi:10.4236/jdaip.2015.34011
“The details of this study have been described elsewhere [8]-[11].”
Self-citationOBSOLETE: Lipids and Cardiovascular Diseases: Epidemiologic Perspectives
Okamura, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99596-5
Self-citationSarnak, M. J., Bloom, R. D., Muntner, P., Rahman, M., Saland, J. M., & Fried, L. P. (2014)
Comprehensive risk assessment for the prevention of atherosclerotic diseases
Okamura, T. (2018) · Journal of the Japanese Coronary Association · doi:10.7793/jcoron.24.002
Self-citationBaek, S., Evangelista, L. S., & Kim, Y. (2018) · IJASS(International Journal of Applied Sports Sciences) · doi:10.24985/ijass.2018.30.1.20
“It is interesting that the FRS has been reported to likely predict CVD risks more accurately in Americans than in non-Americans, and in European Americans and African Americans than in Hispanic and Native Americans, although this needs to be further verified (Brindle et al., 2003; Nishimura et al., 2014; Riddell et al…”
BackgroundKishimoto, N., Moriyama, K., Yamada, C., Oda, K., Urata, N., Sakuma, I., & Nishizaki, Y. (2018) · Health Evaluation and Promotion · doi:10.7143/jhep.45.579
Ohno, Y., Takenaka, T., & Suzuki, H. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1545848
Lipid Management for Prevention of Atherosclerotic Cardiovascular Diseases
Yamashita, S. (2018) · Health Evaluation and Promotion · doi:10.7143/jhep.45.755
Matsuda, M., Kada, A., Saito, A. M., & Hasegawa, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022843
2. Pathophysiology of Atherosclerosis and Its Prevention and Treatment
Yamashita, S. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.1685
II. Prevention of Cardiac-events by Treatments of Lifestyle Diseases
Morooka, T., & Node, K. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.673
脳心血管病の現状と課題 超高齢社会における健康長寿のための保健医療:先制予防医療の可能性
伊澤, 淳. (2018) · Institutional Repositories DataBase (IRDB) · doi:10.11441/shinshumedj.66.307
Kusumi, I., Inoue, S., Baba, K., Nosaka, T., & Anzai, T. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02987-1
Saigusa, T., Watanabe, K., Hada, Y., Ishii, K., Kameda, W., Susa, S., Ishizawa, K., & Ishihara, H. (2021) · Research Square · doi:10.21203/rs.3.rs-876077/v1
Algunos problemas en torno a los tipos y subtipos de suplemento
Dolader, D. S. (2002) · Archivo de filología aragonesa/Archivo de filología aragonesa
2. Pathophysiology of Atherosclerosis and Its Prevention and Treatment
Yamashita, S. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.96a
Lipids and Cardiovascular Diseases: Epidemiologic Perspectives
Okamura, T., Sugiyama, D., Hirata, T., Kuwabara, K., & Hirata, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99596-6
Self-citationDas, S., Biswas, L., Mukherjee, T., Biswas, K., & Pal, S. K. (2022) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v13i8.45309
Metadata
- Authors
- Nishimura, K., Okamura, T., Watanabe, M., Nakai, M., Takegami, M., Higashiyama, A., Kokubo, Y., Okayama, A., & Miyamoto, Y.
- Affiliations
- National Cerebral and Cardiovascular Center (JP)
- Keio University (JP)
- Hyogo Medical University (JP)
- Japan Anti Tuberculosis Association (JP)
- ORCID
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2014
- Volume
- 21
- Issue
- 8
- Pages
- 784-798
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- PMC
- PMC5090819
- OpenAlex
- W2043022783
- Cited by
- 228
- References
- 58
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 25 · 2023: 25 · 2022: 34 · 2021: 33 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 10 · 2016: 12 · 2015: 4 · 2014: 2
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Journal of Atherosclerosis and Thrombosis (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cerebral and Cardiovascular Center (22-4-5)
- Japan Society for the Promotion of Science (25293147)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- coronary artery disease, Framingham risk score, risk prediction model, Japanese population, chronic kidney disease, Suita Study, risk overestimation, net reclassification improvement, 10-year risk, urban population
- MeSH terms
- Adult, Aged, Algorithms, Coronary Disease, Female, Follow-Up Studies, Humans, Japan, Male, Middle Aged, Prognosis, Risk Factors, Urban Population, Cohort Studies, Biomarkers, Incidence, Proportional Hazards Models, Case-Control Studies, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review